Isomorphic Labs · Series A
London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug
Amount
$600M
Round
Series A
Valuation
—
Announced
—
Investors
Participating investors
London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug
Amount
$600M
Round
Series A
Valuation
—
Announced
—
Participating investors